Question 1

What is the catalog number for Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor?

Accepted Answer

The catalog number for Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor is TBI1535-50MG.

Question 2

What sizes are available for Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor?

Accepted Answer

Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor is available in the following size(s): 50 mg.

Question 3

Is Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor in stock?

Accepted Answer

Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Tyrphostin 9, PDGFRK inhibitor; Oxidative phosphorylation Inhibitor

Product Specifications

Shipping Conditions

Frequently Asked Questions

Explore Other Products

Cytokeratin 18 (KRT18/835), 0.2mg/mL

Neurofilament (NF-L) (NFL/736), CF740 conjugate, 0.1mg/mL

Anti-Cytokeratin 8/KRT8 Antibody Picoband®, Carrier-free

NFE2 Recombinant Rabbit Monoclonal Antibody [JE65-92]

CD10 (Membrane Metalloendopeptidase) (MME/2590), CF568 conjugate, 0.1mg/mL

Phospho-p53 Antibody (pS315)